HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.

Abstract
Neurofibromatosis type 1 (NF1) is a common neurogenetic condition characterized by significant clinical heterogeneity. A major barrier to developing precision medicine approaches for NF1 is an incomplete understanding of the factors that underlie its inherent variability. To determine the impact of the germline NF1 gene mutation on the optic gliomas frequently encountered in children with NF1, we developed genetically engineered mice harboring two representative NF1-patient-derived Nf1 gene mutations (c.2542G>C;p.G848R and c.2041C>T;p.R681X). We found that each germline Nf1 gene mutation resulted in different levels of neurofibromin expression. Importantly, only R681X(CKO) but not G848R(CKO), mice develop optic gliomas with increased optic nerve volumes, glial fibrillary acid protein immunoreactivity, proliferation and retinal ganglion cell death, similar to Nf1 conditional knockout mice harboring a neomycin insertion (neo) as the germline Nf1 gene mutation. These differences in optic glioma phenotypes reflect both cell-autonomous and stromal effects of the germline Nf1 gene mutation. In this regard, primary astrocytes harboring the R681X germline Nf1 gene mutation exhibit increased basal astrocyte proliferation (BrdU incorporation) indistinguishable from neo(CKO) astrocytes, whereas astrocytes with the G848R mutation have lower levels of proliferation. Evidence for paracrine effects from the tumor microenvironment were revealed when R681X(CKO) mice were compared with conventional neo(CKO) mice. Relative to neo(CKO) mice, the optic gliomas from R681X(CKO) mice had more microglia infiltration and JNK(Thr183/Tyr185) activation, microglia-produced Ccl5, and glial AKT(Thr308) activation. Collectively, these studies establish that the germline Nf1 gene mutation is a major determinant of optic glioma development and growth through by both tumor cell-intrinsic and stromal effects.
AuthorsJoseph A Toonen, Corina Anastasaki, Laura J Smithson, Scott M Gianino, Kairong Li, Robert A Kesterson, David H Gutmann
JournalHuman molecular genetics (Hum Mol Genet) Vol. 25 Issue 9 Pg. 1703-13 (05 01 2016) ISSN: 1460-2083 [Electronic] England
PMID26908603 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural)
Copyright© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected].
Chemical References
  • Glial Fibrillary Acidic Protein
  • Neurofibromin 1
Topics
  • Animals
  • Astrocytes (metabolism, pathology)
  • Cells, Cultured
  • Disease Models, Animal
  • Female
  • Germ-Line Mutation (genetics)
  • Glial Fibrillary Acidic Protein (metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microglia (metabolism, pathology)
  • Neurofibromatosis 1 (complications)
  • Neurofibromin 1 (genetics)
  • Optic Nerve (metabolism, pathology)
  • Optic Nerve Glioma (etiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: